肿瘤标志物CA125Ⅱ、CA199测定在原发性肝癌诊断中的应用
Medical Innovation of China(2013)
Abstract
目的:探讨肿瘤标志物CA125Ⅱ与CA199联合检测在原发性肝癌(PHC)中的诊断价值。方法:对原发性肝癌(PHC)组60例、肝良性疾病组40例(肝硬化组20例,乙肝、丙肝组20例)和正常对照组30例,检测血清CA125Ⅱ和CA199水平。结果:PHC组血清CA125Ⅱ、CA199水平均明显高于肝良性疾病组和正常对照组,差异有统计学意义(P<0.05)。PHC组血清CA125Ⅱ和CA199阳性率分别为82.0%、75.0%,CA125Ⅱ、CA199联检阳性率为90.0%。结论:血清CA125Ⅱ和CA199联合检测可明显提高PHC阳性检出率,对于肝硬化和原发性肝癌的监测和诊断有很高的价值。
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined